Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 June 2025
Veterinary medicines European public assessment report (EPAR): Biobhyo, Swine dysentery vaccine (inactivated), Status: Opinion
Summary of opinion: Poulvac E. coli, 12/06/2025 Negative
Summary of opinion: NexGard, 12/06/2025 Positive
Summary of opinion: Nexgard Spectra, 12/06/2025 Positive
PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy
Summary of opinion: Daxocox, 12/06/2025 Positive
Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Date of authorisation: 04/02/2002, Revision: 60, Status: Authorised
Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 26, Status: Authorised